# Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

> **NCT00324805** · PHASE3 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 1501 (actual)

## Conditions studied

- Stage IB Lung Non-Small Cell Carcinoma AJCC v7
- Stage IIA Lung Non-Small Cell Carcinoma AJCC v7
- Stage IIB Lung Non-Small Cell Carcinoma AJCC v7
- Stage IIIA Lung Non-Small Cell Cancer AJCC v7

## Interventions

- **BIOLOGICAL:** Bevacizumab
- **DRUG:** Cisplatin
- **DRUG:** Docetaxel
- **DRUG:** Gemcitabine Hydrochloride
- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** Pemetrexed Disodium
- **OTHER:** Questionnaire Administration
- **DRUG:** Vinorelbine Tartrate

## Key facts

- **NCT ID:** NCT00324805
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07-19
- **Primary completion:** 2015-10-20
- **Final completion:** 2025-01-31
- **Target enrollment:** 1501 (ACTUAL)
- **Last updated:** 2025-03-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00324805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00324805, "Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00324805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*